| pubmed-article:15086926 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15086926 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15086926 | lifeskim:mentions | umls-concept:C0001924 | lld:lifeskim |
| pubmed-article:15086926 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:15086926 | lifeskim:mentions | umls-concept:C0730345 | lld:lifeskim |
| pubmed-article:15086926 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:15086926 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
| pubmed-article:15086926 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:15086926 | pubmed:dateCreated | 2004-4-16 | lld:pubmed |
| pubmed-article:15086926 | pubmed:abstractText | Microalbuminuria is regarded as the most important predictor of high risk for the development of diabetic nephropathy. Early detection may allow treatment to prevent progression to persistent albuminuria and renal failure. Recent studies have shown that conventional immunoassays underestimate urinary albumin concentration, as albumin in urine may exist in two forms, immuno-reactive and immuno-unreactive. The present study examines the differential lead-time for the development of microalbuminuria as measured by both conventional radioimmunoassay (RIA; measures immuno-reactive) and high-performance liquid chromatography (HPLC; measures total albumin = immuno-reactive plus immuno-unreactive) analysis in both type 1 and type 2 diabetic patients. | lld:pubmed |
| pubmed-article:15086926 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15086926 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15086926 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15086926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15086926 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15086926 | pubmed:month | May | lld:pubmed |
| pubmed-article:15086926 | pubmed:issn | 0085-2538 | lld:pubmed |
| pubmed-article:15086926 | pubmed:author | pubmed-author:OsickaTanya... | lld:pubmed |
| pubmed-article:15086926 | pubmed:author | pubmed-author:JerumsGeorgeG | lld:pubmed |
| pubmed-article:15086926 | pubmed:author | pubmed-author:ComperWayne... | lld:pubmed |
| pubmed-article:15086926 | pubmed:author | pubmed-author:MacIsaacRicha... | lld:pubmed |
| pubmed-article:15086926 | pubmed:author | pubmed-author:ClarkMalcomM | lld:pubmed |
| pubmed-article:15086926 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15086926 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:15086926 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15086926 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15086926 | pubmed:pagination | 1850-5 | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:meshHeading | pubmed-meshheading:15086926... | lld:pubmed |
| pubmed-article:15086926 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15086926 | pubmed:articleTitle | Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. | lld:pubmed |
| pubmed-article:15086926 | pubmed:affiliation | Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia. wayne.comper@med.monash.edu.au | lld:pubmed |
| pubmed-article:15086926 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15086926 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15086926 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15086926 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15086926 | lld:pubmed |
